DBP International AB: European patent for Temodex / SI-053 is granted
Double Bond Pharmaceutical International AB (publ) ("DBP" or "The Company", org. No. 556991-6082) has today, February 20, 2020, received information on granting a European patent application concerning the company's front-line product Temodex / SI-053 . Patent approval provides protection for the technology and the product in 26 European Patent Organization (EPO) countries at least until 2036. "This is a very important milestone in the development of SI-053 as Europe is an important regulated market where we plan to expand the global commercialization of the product," comments Igor